| Peter Pyrko, MD, PHD | |
|
11190 Warner Ave Ste 300, Fountain Valley, CA 92708-4045 | |
| (714) 241-7000 | |
| (714) 241-7003 |
| Full Name | Peter Pyrko |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 11190 Warner Ave Ste 300, Fountain Valley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467695056 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | A137232 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorialcare Orange Coast Medical Center | Fountain valley, CA | Hospital |
| Fountain Valley Regional Hospital & Medical Center | Fountain valley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthowest | 3072932623 | 33 |
News Archive
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
The results of a study presented today at the European League Against Rheumatism Annual Congress show for the first time that an individual's exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE).
› Verified 4 days ago
| Entity Name | John P. Kelly, M.d., A Professional Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558586438 PECOS PAC ID: 8628122546 Enrollment ID: O20090812000198 |
News Archive
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
The results of a study presented today at the European League Against Rheumatism Annual Congress show for the first time that an individual's exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE).
› Verified 4 days ago
| Entity Name | Shahin S Rad Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801265673 PECOS PAC ID: 3870803299 Enrollment ID: O20151113001316 |
News Archive
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
The results of a study presented today at the European League Against Rheumatism Annual Congress show for the first time that an individual's exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE).
› Verified 4 days ago
| Entity Name | Orthowest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760007330 PECOS PAC ID: 3072932623 Enrollment ID: O20200930002560 |
News Archive
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
The results of a study presented today at the European League Against Rheumatism Annual Congress show for the first time that an individual's exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Pyrko, MD, PHD 11190 Warner Ave Ste 300, Fountain Valley, CA 92708-4045 Ph: (714) 241-7000 | Peter Pyrko, MD, PHD 11190 Warner Ave Ste 300, Fountain Valley, CA 92708-4045 Ph: (714) 241-7000 |
News Archive
Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.
The results of a study presented today at the European League Against Rheumatism Annual Congress show for the first time that an individual's exposure to air pollution may have a direct role in triggering disease activity as well as airway inflammation in children and adolescents with Systemic Lupus Erythematosus (SLE).
› Verified 4 days ago
Jawad Khan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11190 Warner Ave Ste 300, Fountain Valley, CA 92708 Phone: 714-241-7000 Fax: 714-241-7003 | |
Dr. Kenneth L Chambers, M.D., M.P.H Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11160 Warner Avenue, 311, Fountain Valley, CA 92708 Phone: 714-850-7300 Fax: 714-957-7348 | |
Jeffrey Wong, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 18785 Brookhurst St Ste 100, Fountain Valley, CA 92708 Phone: 714-500-5056 Fax: 949-540-7148 | |
Dr. Richard Charles Raczka, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11190 Warner Ave Ste 300, Fountain Valley, CA 92708 Phone: 714-241-7000 Fax: 714-241-7003 | |
Richard Yd Lin, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11190 Warner Ave, Suite 306, Fountain Valley, CA 92708 Phone: 714-432-9990 Fax: 714-432-9988 | |
Dr. Daniel Terah Stein, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 11160 Warner Ave Ste 311, Fountain Valley, CA 92708 Phone: 714-850-7300 Fax: 714-850-7310 | |
Keun-heng Huo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 18035 Brookhurst St, Ste 1200, Fountain Valley, CA 92708 Phone: 949-691-3131 Fax: 949-940-8311 |